Inter Pharma PCL (BKK:IP)

Market Cap	2.26B
Revenue (ttm)	2.05B
Net Income (ttm)	72.22M
Shares Out	605.34M
EPS (ttm)	0.12
PE Ratio	31.35
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	722,643
Average Volume	627,811
Open	3.800
Previous Close	3.800
Day's Range	3.740 - 3.800
52-Week Range	2.020 - 5.150
Beta	0.47
RSI	67.05
Earnings Date	Nov 11, 2025

About Inter Pharma PCL

Inter Pharma Public Company Limited manufactures, imports, and distributes drug and dietary supplement products for humans and animals in Thailand. It operates through three segments: Human healthcare, Animal healthcare, and Hospital and clinics. The company offers healthcare, anti-aging, and human beauty products, such as medical supplies, nutrition therapy, cosmetics, supplementary food, probiotic and prebiotic products, health and general food products, pharmaceuticals and cosmeceuticals products, functional food and drinks, and medical equi...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2006
• Country: Thailand
• Stock Exchange: Stock Exchange of Thailand
• Ticker Symbol: IP

Financial Performance

In 2024, Inter Pharma PCL's revenue was 1.91 billion, an increase of 6.29% compared to the previous year's 1.80 billion. Earnings were 37.28 million, a decrease of -26.60%.